OpenEvidence Integrates AI Clinical Tools into OneOncology’s Oncology Platform
Event summary
- OpenEvidence and OneOncology have partnered to integrate OpenEvidence’s AI-powered clinical decision-support platform into OneOncology’s workflow tools.
- The integration aims to streamline evidence retrieval for physicians at OneOncology’s partner practices, which serve 1.5 million patients nationwide.
- Future expansion may include deeper integration with genomic data and clinical trials matching systems.
- Over half of U.S. hematology/oncology physicians already use OpenEvidence for clinical decision-making.
The big picture
This partnership aligns with the growing trend of AI-driven tools being embedded into clinical workflows to improve efficiency and patient outcomes. With over half of U.S. oncologists already using OpenEvidence, this integration could further solidify its position in community oncology settings, where managing complex treatment pathways is critical.
What we're watching
- Adoption Pace
- How quickly OneOncology’s physicians will integrate OpenEvidence into their workflows and whether this drives broader adoption in community oncology.
- Data Integration
- The pace at which OpenEvidence and OneOncology expand integration to include genomic data and clinical trials matching, enhancing precision oncology capabilities.
- Competitive Response
- Whether competitors in AI-powered clinical decision support will respond with similar partnerships or feature enhancements.
Related topics